Market Research Trends

The global neurointerventional devices market is predicted to develop at a CAGR of 4.7% from 2022 to 2030, with a market value of roughly US$ 2.5 billion in 2022. According to Future Market Insights, hospitals will account for more than 90.4% of the global market by end user in 2021. According to the study, the market will reach US$ 3.6 Billion in revenues by the end of 2030. Since the past several years, the burden of neurological disorders has increased multifold. According to the National Center for Biotechnology Information (NCBI), the frequency of cerebral aneurysm is nearly 3.2%, with the prevalence being higher amongst women than men above 50 years of age. It is estimated that around 6.5 million people in the United States possess an unruptured brain aneurysm, while 30,000 suffer a brain aneurysm rupture every year. Based on these trends, it is unsurprising to observe the market being interspersed with the presence of several reputed manufacturers who constantly launch new prod...

According to a new report from Future Market Insights (FMI), the global Neurointerventional Devices Market will grow at a 4.7% CAGR through 2030. According to the study, the market will be worth $3.6 billion by the end of 2030. Data Points Market Insights Market Value 2021 US$ 2.4 Bn Market Value 2022 US$ 2.5 Bn Market Value 2030 US$ 3.6 Bn CAGR 2022-2030 4.7% Market Share of Top 5 Countries 72.5% Key Market Players Stryker Corporation, Penumbra Inc., Covidien Public Limited, Johnson & Johnson Private Limited and Terumo Corporation The prevalence of neurological disorders has more than tripled in recent years. According to the National Center for Biotechnology Information (NCBI), the prevalence of cerebral aneurysm is nearly 3.2%, with women being more likely than men over the age of 50. It is estimated that approxima...